Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

FRA/RMY stock hub

FRA/RMY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/RMYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/RMY

In the news

Latest news · FRA/RMY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.3

P25 n/aP50 n/aP75 n/a

Trailing P/E33.6

P25 n/aP50 n/aP75 n/a

ROE5.1

P25 n/aP50 n/aP75 n/a

ROIC4.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/RMY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

AUD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	DE
Employees	92,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 12.8B
Exchange	Frankfurt Stock Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	EUR 5.2B
Price	EUR 22.4
Price currency	EUR
Rev Per Employee	114,970.46x
Sic	8062
Symbol	fra/RMY
Website	https://www.ramsayhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.98%
EV Earnings	82.52x
EV/EBIT	19.64x
EV/EBITDA	9.46x
EV/FCF	31.61x
EV/Sales	1.12x
FCF yield	7.77%
Forward P/E	24.29x
P/B ratio	1.6x
P/E ratio	33.59x
P/S ratio	0.49x
PE Ratio10 Y	195.92x
PE Ratio3 Y	564.99x
PE Ratio5 Y	345.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.69%
EBITDA Margin	8.91%
FCF margin	3.83%
Gross margin	11.87%
Gross Profit	EUR 1.3B
Gross Profit Growth	4.47%
Gross Profit Growth Q	9.58%
Gross Profit Growth3 Y	3.14%
Gross Profit Growth5 Y	6.09%
Net Income	EUR 155.1M
Net Income Growth	1,044.66%
Net Income Growth3 Y	-32.1%
Net Income Growth5 Y	-0.86%
Pretax Margin	2.32%
Profit Margin	1.56%
Profit Per Employee	EUR 1,686
ROA	3.13
Roa5y	2.38
ROCE	5.97
ROE	5.11
Roe5y	6.59
ROIC	4.09
Roic5y	3.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.7%
Cagr15y	5.74%
Cagr1y	17.4%
Cagr3y	-13.66%
Cagr5y	-9.47%
Div CAGR10	-3.71%
Div CAGR3	-9.53%
Div CAGR5	9.06%
EPS Growth	3,444.2
EPS Growth3 Y	-32.23
EPS Growth5 Y	-1.02
FCF Growth	8.74%
FCF Growth3 Y	9.75%
FCF Growth5 Y	4.99%
OCF Growth	10.63%
OCF Growth Q	16.92%
OCF Growth10 Y	-2.94%
OCF Growth3 Y	5.81%
OCF Growth5 Y	3.66%
Revenue Growth	8.95x
Revenue Growth Q	9.71x
Revenue Growth3 Y	3.77x
Revenue Growth5 Y	4.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.88
Assets	EUR 12.3B
Cash	EUR 267M
Current Assets	EUR 2.2B
Current Liabilities	EUR 2.4B
Debt	EUR 6.7B
Debt EBITDA	EUR 5.4
Debt Equity	EUR 2.07
Debt FCF	EUR 16.66
Equity	EUR 3.3B
Interest Coverage	1.72
Liabilities	EUR 9.1B
Long Term Assets	EUR 10.1B
Long Term Liabilities	EUR 6.6B
Net Cash	EUR -6.5B
Net Cash By Market Cap	EUR -124
Net Debt EBITDA	EUR 6.87
Net Debt Equity	EUR 1.99
Net Debt FCF	EUR 16
Tangible Book Value	EUR -866.1M
Tangible Book Value Per Share	EUR -3.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.9
Inventory Turnover	40.63
Net Working Capital	EUR -112.6M
Quick ratio	0.71
Working Capital	EUR -222.4M
Working Capital Turnover	EUR -30.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.5%
Dividend Growth	0.66%
Dividend Growth Years	0%
Dividend per share	EUR 0.48
Dividend Years	19
Dividend Yield	2.15%
Ex Div Date	2026-03-09
Last Dividend	EUR 0.26
Payout Frequency	Semi-Annual
Payout Ratio	62.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-38.18%
1Y total return	17.38%
200-day SMA	20.79
3Y total return	-35.65%
50-day SMA	24.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-39.2%
All Time High	57
All Time High Change	-60.7%
All Time High Date	2022-04-21
All Time Low	5.83
All Time Low Change	284.22%
All Time Low Date	2009-07-24
ATR	0.31
Ch YTD	15.46
High	22.4
High52	26.6
High52 Date	2026-03-06
High52ch	-15.79%
Low	22.4
Low52	17.1
Low52 Date	2025-11-11
Low52ch	30.99%
Ma50ch	-7.7%
Price vs 200-day SMA	7.73%
RSI	34.94
RSI Monthly	46.47
RSI Weekly	51.1
Sharpe ratio	0.36x
Sortino ratio	0.79
Total Return	1.65%
Tr YTD	16.59
Tr15y	131.03%
Tr1m	-3.45%
Tr1w	-3.45%
Tr3m	7.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 601.9M
Operating Income Growth	2.44
Operating Income Growth Q	5.07
Operating Income Growth3 Y	0.51
Operating Income Growth5 Y	10.01
Operating margin	5.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182,218,206%
Net Borrowing	-245,512,520
Shares Insiders	1.95%
Shares Institutions	44.77%
Shares Qo Q	0.17%
Shares Yo Y	0.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 398.8M
Average Volume	0x
Bv Per Share	11.83
CAPEX	EUR -465.2M
Ch10y	-48.72
Ch15y	72.44
Ch1m	-3.45
Ch1w	-3.45
Ch1y	14.87
Ch3m	6.67
Ch3y	-39.13
Ch5y	-44.55
Ch6m	30.23
Change	-1.75%
Change From Open	0
Close	22.8
Days Gap	-1.75
Depreciation Amortization	368,975,865.9
Earnings Date	2026-08-27
EBIT	EUR 601.9M
EBITDA	EUR 942.8M
EPS	EUR 0.67
F Score	5
FCF	EUR 404.8M
FCF EV Yield	3.16x
Financing CF	-353,019,197
Fiscal Year End	June
Founded	1,964
Graham Number	14.48269
Graham Upside	-35.35
Income Tax	EUR 83.2M
Investing CF	-457,152,474
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	EUR 3.33
Lynch Upside	-85.12
Ma150	21.07
Ma150ch	6.3%
Ma20	23.83
Ma20ch	-6%
Net CF	72,660,372
Next Earnings Date	2026-08-27
Open	22.4
P FCF Ratio	12.87
P OCF Ratio	5.99
Payment Date	2026-03-26
Ppne	6,709,814,746.8
Price Date	2026-05-08
Price EBITDA	EUR 5.53
Revenue	10,577,282,292x
SBC By Revenue	0.06x
Share Based Comp	6,078,702
Tax By Revenue	0.79x
Tax Rate	33.91%
Tr6m	31.5%
Z Score	1.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/RMY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$0.48 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.1%

0 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2026-03-09

Performance

FRA/RMY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/RMY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.8%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

FRA/RMY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.9

Neutral momentum band

Price vs 200-day MA

+7.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/RMY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/RMY stock rating?

fra/RMY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/RMY analysis?

The full report lives at /stocks/fra/RMY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/RMY?

The latest report frames fra/RMY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/RMY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.